{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:51:00Z","timestamp":1792731060502,"version":"4.5.0"},"reference-count":68,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Thrombosis is a major cause of morbidity and mortality in polycythemia vera (PV) and essential thrombocythemia (ET). The pathophysiology of thrombosis in these disorders remains unclear, and we hypothesized that upregulation of thrombotic, inflammatory, and hypoxia-inducible factor (HIF)\u2013regulated genes may play a role in it. We performed unbiased RNA sequencing in granulocytes and platelets of PV patients and found differential expression of several thrombotic, inflammatory, and HIF-regulated genes. The expression of many of these genes positively correlated with JAK2 expression and JAK2V617F allelic burden. We then validated these findings by quantitative polymerase chain reaction analyses of selected gene transcripts in a larger number of PV and ET granulocytes and platelets (58 patients) and in 28 controls, and we compared these findings in patients with and without thrombosis. The study included 29 females and 29 males; of these, 28 had a history of thrombosis. We found that transcripts of several selected genes were upregulated in patients with PV or ET compared with controls. In granulocytes, the expression levels of F3, SELP, VEGFA, and SLC2A1 were significantly higher in patients with a history of thrombosis compared with those who did not have thrombosis. Patients with a history of thrombosis have significantly higher expression of IL1RAP (P &amp;lt; .05) in platelets compared with those without thrombosis. Our study confirms the presence of a thrombo-inflammatory state and augmented HIF activity in PV and ET and its role in thrombosis. These data may provide the background for targeted therapies in PV and ET.<\/jats:p>","DOI":"10.1182\/bloodadvances.2019001379","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T15:40:06Z","timestamp":1584978006000},"page":"1115-1130","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":79,"title":["Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia"],"prefix":"10.1182","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5542-4754","authenticated-orcid":false,"given":"Radhika","family":"Gangaraju","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"Song","sequence":"first","affiliation":[{"name":"Division of Hematology, School of Medicine, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Hematology, School of Medicine, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2785-866X","authenticated-orcid":false,"given":"Tsewang","family":"Tashi","sequence":"first","affiliation":[{"name":"Division of Hematology, School of Medicine, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi N.","family":"Reeves","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, University of North Carolina, Chapel Hill, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna M.","family":"Sundar","sequence":"first","affiliation":[{"name":"Division of Pulmonology, Critical Care and Sleep Medicine, School of Medicine, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-7036","authenticated-orcid":false,"given":"Perumal","family":"Thiagarajan","sequence":"first","affiliation":[{"name":"Center for Translational Research on Inflammatory Diseases, Michael E. DeBakey Veterans Affairs Medical Center, Department of Medicine and Pathology, Baylor College of Medicine, Houston, TX; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8019-2940","authenticated-orcid":false,"given":"Josef T.","family":"Prchal","sequence":"first","affiliation":[{"name":"Division of Hematology, School of Medicine, University of Utah, Salt Lake City, UT;"},{"name":"Veterans Administration Medical Center, Salt Lake City, UT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2020,3,23]]},"reference":[{"issue":"1","key":"2020032311400378200_B1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","article-title":"A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms","volume":"19","author":"Rungjirajittranon","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"2020032311400378200_B2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"2020032311400378200_B3","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/leu.2013.163","article-title":"Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study","volume":"27","author":"Tefferi","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"2020032311400378200_B4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1160\/th15-04-0326","article-title":"Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment","volume":"115","author":"De Stefano","year":"2016","journal-title":"Thromb Haemost"},{"key":"2020032311400378200_B5","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0049-3848(16)30102-5","article-title":"Molecular biomarkers of thrombosis in myeloproliferative neoplasms","volume":"140","author":"Barbui","year":"2016","journal-title":"Thromb Res"},{"key":"2020032311400378200_B6","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1038\/bcj.2015.94","article-title":"Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia","volume":"5","author":"Barbui","year":"2015","journal-title":"Blood Cancer J"},{"issue":"5","key":"2020032311400378200_B7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11899-017-0400-3","article-title":"Risk factors for and management of MPN-associated bleeding and thrombosis","volume":"12","author":"Martin","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"issue":"2","key":"2020032311400378200_B8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ejh.13070","article-title":"Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemia","volume":"101","author":"Buxhofer-Ausch","year":"2018","journal-title":"Eur J Haematol"},{"issue":"22","key":"2020032311400378200_B9","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients","volume":"117","author":"Carobbio","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2020032311400378200_B10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/leu.2017.150","article-title":"Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era","volume":"31","author":"Falchi","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"2020032311400378200_B11","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1038\/leu.2008.253","article-title":"Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation","volume":"22","author":"Landolfi","year":"2008","journal-title":"Leukemia"},{"issue":"8102","key":"2020032311400378200_B12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(78)92098-6","article-title":"Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia","volume":"2","author":"Pearson","year":"1978","journal-title":"Lancet"},{"issue":"4","key":"2020032311400378200_B13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3324\/haematol.2018.210732","article-title":"Re-evaluation of hematocrit as a determinant of thrombotic risk in erythrocytosis","volume":"104","author":"Gordeuk","year":"2019","journal-title":"Haematologica"},{"key":"2020032311400378200_B14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2017.06.010","article-title":"Inflammation and myeloproliferative neoplasms","volume":"85","author":"Lussana","year":"2017","journal-title":"J Autoimmun"},{"issue":"1","key":"2020032311400378200_B15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.2018.195321","article-title":"Vascular endothelial cell expression of JAK2V617F is sufficient to promote a pro-thrombotic state due to increased P-selectin expression","volume":"104","author":"Guy","year":"2019","journal-title":"Haematologica"},{"issue":"21","key":"2020032311400378200_B16","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1182\/blood-2008-11-191544","article-title":"The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome","volume":"113","author":"Sozer","year":"2009","journal-title":"Blood"},{"issue":"10","key":"2020032311400378200_B17","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood-2003-07-2535","article-title":"Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors","volume":"103","author":"Gordeuk","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2020032311400378200_B18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ng1019","article-title":"Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia","volume":"32","author":"Ang","year":"2002","journal-title":"Nat Genet"},{"key":"2020032311400378200_B19","article-title":"Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms [published online ahead of print 14 November 2019]","author":"Baumeister","journal-title":"Leukemia"},{"issue":"21","key":"2020032311400378200_B20","article-title":"Ph-negative myeloproliferative neoplasms exhibit some features of Warburg effect [abstract]","volume":"122","author":"Navas-Mareno","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2020032311400378200_B21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood-2015-04-638593","article-title":"White blood cell counts and thrombosis in polycythemia vera: a subanalysis of the CYTO-PV study","volume":"126","author":"Barbui","year":"2015","journal-title":"Blood"},{"issue":"5671","key":"2020032311400378200_B22","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/274590a0","article-title":"A common progenitor for human myeloid and lymphoid cells","volume":"274","author":"Prchal","year":"1978","journal-title":"Nature"},{"key":"2020032311400378200_B23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-1-60761-175-2_7","article-title":"PANTHER pathway: an ontology-based pathway database coupled with data analysis tools","volume":"563","author":"Mi","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2020032311400378200_B24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00109-015-1294-y","article-title":"HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis","volume":"93","author":"Song","year":"2015","journal-title":"J Mol Med (Berl)"},{"issue":"24","key":"2020032311400378200_B25","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P-selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur Heart J"},{"issue":"7","key":"2020032311400378200_B26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3109\/09537104.2013.840720","article-title":"Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis","volume":"25","author":"Zetterberg","year":"2014","journal-title":"Platelets"},{"key":"2020032311400378200_B27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3324\/haematol.2018.205989","article-title":"New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches","volume":"104","author":"Bar-Natan","year":"2019","journal-title":"Haematologica"},{"issue":"15","key":"2020032311400378200_B28","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1073\/pnas.0401060101","article-title":"Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis","volume":"101","author":"Monaco","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020032311400378200_B29","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0049-3848(09)70137-9","article-title":"Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model","volume":"123","author":"Sud","year":"2009","journal-title":"Thromb Res"},{"issue":"10","key":"2020032311400378200_B30","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1161\/STROKEAHA.111.622217","article-title":"Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases","volume":"43","author":"Tj\u00e4rnlund-Wolf","year":"2012","journal-title":"Stroke"},{"issue":"1","key":"2020032311400378200_B31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exphem.2006.11.012","article-title":"Polycythemia vera is not initiated by JAK2V617F mutation","volume":"35","author":"Nussenzveig","year":"2007","journal-title":"Exp Hematol"},{"issue":"10","key":"2020032311400378200_B32","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-06-2351","article-title":"Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer","volume":"13","author":"Khorana","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"8","key":"2020032311400378200_B33","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.leu.2404264","article-title":"Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies","volume":"20","author":"L\u00f3pez-Pedrera","year":"2006","journal-title":"Leukemia"},{"issue":"6","key":"2020032311400378200_B34","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1182\/blood-2012-01-404699","article-title":"Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDS","volume":"120","author":"Barreyro","year":"2012","journal-title":"Blood"},{"issue":"37","key":"2020032311400378200_B35","doi-asserted-by":"crossref","first-page":"16280","DOI":"10.1073\/pnas.1004408107","article-title":"Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein","volume":"107","author":"J\u00e4r\u00e5s","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2020032311400378200_B36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1403141","article-title":"Two clinical phenotypes in polycythemia vera","volume":"371","author":"Spivak","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2020032311400378200_B37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1034\/j.1600-0609.2001.00359.x","article-title":"Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count","volume":"66","author":"Jensen","year":"2001","journal-title":"Eur J Haematol"},{"issue":"7","key":"2020032311400378200_B38","doi-asserted-by":"crossref","first-page":"e102259","DOI":"10.1371\/journal.pone.0102259","article-title":"MicroRNA expression differences in human hematopoietic cell lineages enable regulated transgene expression","volume":"9","author":"Teruel-Montoya","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"2020032311400378200_B39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types","volume":"26","author":"Monaco","year":"2019","journal-title":"Cell Rep"},{"issue":"9","key":"2020032311400378200_B40","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1055\/s-0038-1667015","article-title":"Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features","volume":"118","author":"Guadall","year":"2018","journal-title":"Thromb Haemost"},{"key":"2020032311400378200_B41","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/j.thromres.2010.01.032","article-title":"Tissue factor expression in blood cells","volume":"125","author":"\u00d8sterud","year":"2010","journal-title":"Thromb Res"},{"issue":"4","key":"2020032311400378200_B42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ajh.21974","article-title":"Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera","volume":"86","author":"Panova-Noeva","year":"2011","journal-title":"Am J Hematol"},{"issue":"5","key":"2020032311400378200_B43","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.3324\/haematol.2016.158170","article-title":"Prospective study of thrombosis and thrombospondin-1 expression in Chuvash polycythemia","volume":"102","author":"Sergueeva","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"2020032311400378200_B44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/cvr\/cvv243","article-title":"HIF-2\u03b1-mediated induction of pulmonary thrombospondin-1 contributes to hypoxia-driven vascular remodelling and vasoconstriction","volume":"109","author":"Labrousse-Arias","year":"2016","journal-title":"Cardiovasc Res"},{"issue":"4","key":"2020032311400378200_B45","first-page":"615","article-title":"C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort","volume":"102","author":"Folsom","year":"2009","journal-title":"Thromb Haemost"},{"issue":"12","key":"2020032311400378200_B46","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"2020032311400378200_B47","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ajh.23295","article-title":"Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis","volume":"87","author":"Vaidya","year":"2012","journal-title":"Am J Hematol"},{"key":"2020032311400378200_B48","doi-asserted-by":"crossref","first-page":"670580","DOI":"10.1155\/2015\/670580","article-title":"Circulating cytokine levels as markers of inflammation in Philadelphia negative myeloproliferative neoplasms: Diagnostic and prognostic interest","volume":"2015","author":"Mondet","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"10","key":"2020032311400378200_B49","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1172\/JCI90312","article-title":"JAK2-V617F promotes venous thrombosis through \u03b21\/\u03b22 integrin activation","volume":"128","author":"Edelmann","year":"2018","journal-title":"J Clin Invest"},{"issue":"2","key":"2020032311400378200_B50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2010.031070","article-title":"Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3","volume":"96","author":"Barbui","year":"2011","journal-title":"Haematologica"},{"issue":"22","key":"2020032311400378200_B51","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","article-title":"Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis","volume":"123","author":"Rampal","year":"2014","journal-title":"Blood"},{"issue":"3","key":"2020032311400378200_B52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/febs.13578","article-title":"NF-\u03baB and HIF crosstalk in immune responses","volume":"283","author":"D\u2019Ignazio","year":"2016","journal-title":"FEBS J"},{"issue":"14","key":"2020032311400378200_B53","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?","volume":"119","author":"Hasselbalch","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2020032311400378200_B54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCRESAHA.112.274241","article-title":"Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis","volume":"112","author":"Panigrahi","year":"2013","journal-title":"Circ Res"},{"issue":"15","key":"2020032311400378200_B55","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.molimm.2008.06.023","article-title":"The interleukin-1 receptor associated kinase 1 contributes to the regulation of NFAT","volume":"45","author":"Wang","year":"2008","journal-title":"Mol Immunol"},{"issue":"6","key":"2020032311400378200_B56","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.thromres.2012.08.002","article-title":"HIF1 signalling regulates venous thrombus resolution","volume":"130","author":"Evans","year":"2012","journal-title":"Thromb Res"},{"issue":"3","key":"2020032311400378200_B57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MBC.0b013e32835bfdb9","article-title":"Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?","volume":"24","author":"Zangari","year":"2013","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"2020032311400378200_B58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.thromres.2014.06.009","article-title":"Association between obstructive sleep apnea and deep vein thrombosis \/ pulmonary embolism: a population-based retrospective cohort study","volume":"134","author":"Peng","year":"2014","journal-title":"Thromb Res"},{"issue":"4","key":"2020032311400378200_B59","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1034\/j.1399-3003.2000.16d14.x","article-title":"Platelet function in patients with obstructive sleep apnoea syndrome","volume":"16","author":"Sanner","year":"2000","journal-title":"Eur Respir J"},{"issue":"3","key":"2020032311400378200_B60","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-2006-939441","article-title":"Vascular complications in Chuvash polycythemia","volume":"32","author":"Gordeuk","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"2020032311400378200_B61","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.bbadis.2016.01.017","article-title":"EPAS1\/HIF-2 alpha-mediated downregulation of tissue factor pathway inhibitor leads to a pro-thrombotic potential in endothelial cells","volume":"1862","author":"Stavik","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2020032311400378200_B62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.thromres.2017.07.013","article-title":"A novel hypoxia response element regulates oxygen-related repression of tissue factor pathway inhibitor in the breast cancer cell line MCF-7","volume":"157","author":"Cui","year":"2017","journal-title":"Thromb Res"},{"issue":"8","key":"2020032311400378200_B63","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41375-018-0080-6","article-title":"Pegylated interferon Alfa-2a and hydroxyurea in polycythemia vera and essential thrombocythemia: differential cellular and molecular responses","volume":"32","author":"Tashi","year":"2018","journal-title":"Leukemia"},{"issue":"6","key":"2020032311400378200_B64","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.molcel.2014.01.026","article-title":"Fold change of nuclear NF-\u03baB determines TNF-induced transcription in single cells","volume":"53","author":"Lee","year":"2014","journal-title":"Mol Cell"},{"issue":"1","key":"2020032311400378200_B65","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000339045","article-title":"Role of IRAK1 on TNF-induced proliferation and NF-\u0138B activation in human bone marrow mesenchymal stem cells","volume":"30","author":"Kim","year":"2012","journal-title":"Cell Physiol Biochem"},{"issue":"18","key":"2020032311400378200_B66","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood.2019000428","article-title":"Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea","volume":"134","author":"Yacoub","year":"2019","journal-title":"Blood"},{"issue":"12","key":"2020032311400378200_B67","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1038\/s41375-019-0524-7","article-title":"A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis","volume":"33","author":"Mascarenhas","year":"2019","journal-title":"Leukemia"},{"issue":"23","key":"2020032311400378200_B68","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.1182\/blood-2013-10-531103","article-title":"Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?","volume":"122","author":"Heine","year":"2013","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/6\/1115\/1719724\/advancesadv2019001379.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/4\/6\/1115\/1719724\/advancesadv2019001379.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T15:40:37Z","timestamp":1584978037000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/4\/6\/1115\/452725\/Thrombotic-inflammatory-and-HIFregulated-genes-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,23]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2019001379","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,23]]}}}